Last fiscal, bulk
drugs exporters had ‘not so good’ experience in business. However,
exporters have higher expectations from this fiscal year due to price hike in
domestic market. The bulk drugs exporting industry believes that the prices of
APIs (Active Pharmaceutical Ingredients) can rise up to 15% due to inflation.
The domestic bulk drugs exporters in India also blame the stiff competition in the market between
locals and imported drugs from China has resulted in price hike. India and
China are two major leaders in bulk drugs or APIs industry. Both the countries
cater up to 50% of global bulk drug production.
Do you know the regulatory procedures for releasing new bulk drug in the industry?
Introducing new bulk drug is highly expensive proposition
that includes scientific research, validation trails, and risk of costly
failures. Not any company can afford the formulation and R &D facilities
for launching new bulk drug in the market. Some multinational companies claim
that they had spent $800m for releasing a new drug and they filed an
investigational new drug application prior regulatory procedure.
China is a top supplier of bulk drugs and India is second. What’s the real reason behind it?
It is true that India is the second largest veterinary drugs suppliers. It is due to the
low costing bulk drugs supplied by China in the market and this diminishes the
exporting of Indian bulk drugs in the pharma sector. Moreover, the Indian bulk
drug market value is US$ 13.5 billion, whereas Chinese market value is US$ 30
billion. The only reason behind this ranking is the low costing bulk drugs
offered by China.
Do low costing bulk drugs suppliers meet quality standards?
Of course not, India holds second position in the list of bulk drug exporters. Indian
manufacturers of bulk drugs consider quality standards at first. That’s why
Indian drug manufacturers ignore Chinese bulk drugs due to inferior quality
production.
Generally veterinary products are having properties to treat and prevent disease in animals. The domestic drug companies have to take care about the proportion of various chemicals while manufacturing these drugs.
Generally veterinary products are having properties to treat and prevent disease in animals. The domestic drug companies have to take care about the proportion of various chemicals while manufacturing these drugs.
Sign up here with your email
ConversionConversion EmoticonEmoticon